Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16026361rdf:typepubmed:Citationlld:pubmed
pubmed-article:16026361lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0025598lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0061323lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0071097lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:16026361lifeskim:mentionsumls-concept:C1518321lld:lifeskim
pubmed-article:16026361pubmed:issue8lld:pubmed
pubmed-article:16026361pubmed:dateCreated2005-7-19lld:pubmed
pubmed-article:16026361pubmed:abstractTextTo compare the metabolic effects of pioglitazone, metformin, and glimepiride in the treatment of Japanese patients with newly diagnosed Type 2 diabetes.lld:pubmed
pubmed-article:16026361pubmed:languageenglld:pubmed
pubmed-article:16026361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:citationSubsetIMlld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16026361pubmed:statusMEDLINElld:pubmed
pubmed-article:16026361pubmed:monthAuglld:pubmed
pubmed-article:16026361pubmed:issn0742-3071lld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:WatanabeHHlld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:IgarashiKKlld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:SakaiTTlld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:KawasakiTTlld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:YamanouchiTTlld:pubmed
pubmed-article:16026361pubmed:authorpubmed-author:IchiyanagiKKlld:pubmed
pubmed-article:16026361pubmed:issnTypePrintlld:pubmed
pubmed-article:16026361pubmed:volume22lld:pubmed
pubmed-article:16026361pubmed:ownerNLMlld:pubmed
pubmed-article:16026361pubmed:authorsCompleteYlld:pubmed
pubmed-article:16026361pubmed:pagination980-5lld:pubmed
pubmed-article:16026361pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:meshHeadingpubmed-meshheading:16026361...lld:pubmed
pubmed-article:16026361pubmed:year2005lld:pubmed
pubmed-article:16026361pubmed:articleTitleComparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes.lld:pubmed
pubmed-article:16026361pubmed:affiliationDepartment of Internal Medicine, University of Teikyo, Itabashi-ku, Tokyo, Japan. yama@med.teikyo-u.ac.jplld:pubmed
pubmed-article:16026361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16026361pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:16026361pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16026361pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16026361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16026361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16026361lld:pubmed